A fundus photograph is taken in seconds — in a clinic corridor, lights low, patient tired. Most frames come back ordinary. A few carry quiet changes, a microaneurysm here, a blot hemorrhage there, exudates gathering near the macula, that are easy to miss when the reader is rushed, fatigued, or simply human.
RetinaScan AI was built for that moment. It does not stand in for a clinician's judgement. It organizes attention: it confirms the photograph is readable, screens for patterns associated with diabetic retinopathy, and leaves a visible trace of where the model looked — so a qualified reader can decide what the image really says.